NIFTY 50

Indian cancer patients may get access to CAR T-cell therapy in 8 months, says Dr Siddhartha Mukherjee

Updated : September 16, 2019 07:30 PM IST

A company formed by Mukherjee, Shaw and Kush Parmar plans to pioneer care delivery models at a much lesser cost.
CAR T-cells is derived from your own body and is engineered or weaponised to go and kill cancer cells in your body.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV